WY

Wei Yao

IT Intra-Cellular Therapies: 21 patents #9 of 40Top 25%
University of California: 4 patents #2,189 of 18,278Top 15%
SC Shanghai Awinic Technology Co.: 4 patents #4 of 24Top 20%
XC Xi'An Thermal Power Research Institute Co.: 2 patents #30 of 76Top 40%
HT Huazhong University Of Science And Technology: 2 patents #185 of 1,292Top 15%
PU Peking University: 1 patents #279 of 875Top 35%
DC Delta Electronics (Shanghai) Co.: 1 patents #305 of 555Top 55%
📍 New Milford, NJ: #3 of 94 inventorsTop 4%
🗺 New Jersey: #1,317 of 69,400 inventorsTop 2%
Overall (All Time): #74,265 of 4,157,543Top 2%
41
Patents All Time

Issued Patents All Time

Showing 26–41 of 41 patents

Patent #TitleCo-InventorsDate
10716786 Transmucosal and subcutaneous compositions Peng Li, Robert E. Davis 2020-07-21
10688097 Organic compounds Peng Li 2020-06-23
10597395 Preparation of certain substituted 1-(4-fluorophenyl)-4-(2,3,6b,9,10,10a-hexahydro-1H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-YL)butan-1-ones and pharmaceutically acceptable salts thereof John Charles Tomesch, Peng Li, Qiang Zhang, James David Beard, Andrew S. Thompson +2 more 2020-03-24
10496423 Method for opening up data and functions of terminal application based on reconstruction technology Ying Zhang, Huaqian Cai, Gang Huang 2019-12-03
10494401 LLP2A-bisphosphonate conjugates for osteoporosis treatment Kit S. Lam, Ruiwu Liu, Nancy Lane 2019-12-03
10464938 Pharmaceutical compositions comprising ((6bR,10aS)-1-(4-fluorophenyl)-4-(3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl)butan-1-one or pharmaceutically acceptable salts thereof John Charles Tomesch, Peng Li, Qiang Zhang, James David Beard, Andrew S. Thompson +2 more 2019-11-05
10245260 Organic compounds Peng Li, Robert E. Davis, Sharon Mates, Kimberly VANOVER, Gretchen SNYDER 2019-04-02
10221176 Preparation of certain substituted [((6bR,10aS)-2,3,6b,7,8,9,10,10a-octahydro-1H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalines and pharmaceutically acceptable salts thereof John Charles Tomesch, Peng Li, Qiang Zhang, James David Beard, Andrew S. Thompson +2 more 2019-03-05
9751883 Preparation of certain [((6BR,10AS)-2,3,6B,7,8,9,10, 10A-octahydro-1H-pyrido[3′,4′:4,5]pyrrolo [1,2,3-de]quinoxalines and pharmaceutically acceptable salts thereof John Charles Tomesch, Peng Li, Qiang Zhang, James David Beard, Andrew S. Thompson +2 more 2017-09-05
9561256 LLP2A-bisphosphonate conjugates for osteoporosis treatment Kit S. Lam, Ruiwu Liu, Nancy Lane 2017-02-07
9315504 Preparation of 4-((6BR,10AS)-3-methyl-2,3,6B,9,10, 10A-hexahydro-1H-pyrido[3′,4′:4,5]pyrrolo [1,2,3-de]quinoxalin-8-(7H)-yl)-1-(4-fluorophenyl)-1-butanone or a pharmaceutically acceptable salt thereof John Charles Tomesch, Peng Li, Qiang Zhang, James David Beard, Andrew S. Thompson +2 more 2016-04-19
9119884 LLP2A-bisphosphonate conjugates for osteoporosis treatment Kit S. Lam, Ruiwu Liu, Nancy Lane 2015-09-01
8948586 Method and apparatus for laser overlap detection Dongsheng Zhang, Eugene Lee 2015-02-03
8779139 Substituted 2,3,4,4A,5,9B-hexahydro-1H-pyrido[4,3-B]indole derivatives synthesis and uses thereof John Charles Tomesch, Peng Li, Qiang Zhang, James David Beard, Andrew S. Thompson +2 more 2014-07-15
8309722 Substituted heterocycle gamma-carbolines synthesis John Charles Tomesch, Peng Li, Qiang Zhang, James David Beard, Andrew S. Thompson +1 more 2012-11-13
7504430 Maleiimide anti-tumor phosphatase inhibitors Brian I. Carr, Siddhartha Kar, Christopher J. Michejda 2009-03-17